Safety Study of AMG 228 to Treat Solid Tumors

Clinical trial NCT02437916 · TERMINATED

Trial details

NCT number: NCT02437916
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy Advanced Solid Tumors Cancer Oncology Oncology Patients Tumors Melanoma Non-small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Transitional Cell Carinoma of Bladder Colorectal Cancer

Start date: 2015-04-21
Primary completion: 2016-12-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.